- Research works
- 1 fractional, all time
- Citations
- 1 1.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: TVAX Biomedical (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does TVAX Biomedical (United States) publish most on?
By volume in 2022–2025: vaccines and immunoinformatics approaches, Animal Virus Infections Studies, SARS-CoV-2 and COVID-19 Research and Glioma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 2 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 4 Glioma Diagnosis and Treatment Genetics 0 works
- 5 Immune cells in cancer Immunology 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 Immunotherapy and Immune Responses Immunology 0 works
- 8 Immune Cell Function and Interaction Immunology 0 works
- 9 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Lenexa
- American College of Clinical Pharmacy
- Sekisui XenoTech (United States)
- Grantham University
- Rowe Neurology Institute
- National Association of EMS Physicians
- Johnson County Clin-Trials (United States)
- American College of Healthcare Architects
- MISH Hospital and Clinics
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.